Study of 3D Scanning for Adolescent Scoliosis

Sponsor
NSite Medical (Industry)
Overall Status
Recruiting
CT.gov ID
NCT06035952
Collaborator
(none)
70
2
4.3
35
8.2

Study Details

Study Description

Brief Summary

The investigators aim to validate three-dimensional topographical scanning technology as a tool for evaluation of scoliosis. Through the incorporation of 3D topographical technology in the measurement of deformity, the investigators hope to validate a novel approach to quantify deformity progression and provide an accessible alternative to traditional radiographic workup.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: 3D topographical scan

Detailed Description

The study design will be prospective observational. Patients 10 to 18 years old being evaluated or followed for scoliosis will be included. Those unable to complete the consent and assent processes will not be enrolled. Members of the research team will review the clinic schedule through EPIC each week to identify eligible patients. Member of the patient's care team, such as the physician, will introduce the study to the patient. If the patient and the patient's caregivers are interested in learning more and/or participating, a member of the research team will provide study-related information and obtain informed consent via written or electronic consent, assent, and, if necessary, short form consent.

If a patient consents to participate, members of the research team will conduct the 3D topographical scan in a private room in the clinic. This involves 360 degree scans using a smartphone camera. Participants will also receive any standard of care x-rays during the visit. The investigators will then analyze the ability of the 3D smartphone scan to estimate the Cobb Angle measured on the X-ray, to infer the magnitude of the scoliosis deformity.

Study Design

Study Type:
Observational
Anticipated Enrollment :
70 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Validation of 3D Body Surface Modeling for Patient Monitoring in Adolescent Idiopathic Scoliosis
Actual Study Start Date :
Aug 7, 2023
Anticipated Primary Completion Date :
Oct 15, 2023
Anticipated Study Completion Date :
Dec 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Intervention

This study will have one cohort. This group of patients will undergo 3D scanning with a smartphone, and will also have standard of care diagnostics, such as an X-ray.

Diagnostic Test: 3D topographical scan
Subjects will undergo a quick, radiation-free, no contact 3D scan using a smartphone.

Outcome Measures

Primary Outcome Measures

  1. Accuracy of scanning device to predict clinically significant Cobb Angle [Through study completion, an average of 3 months]

    The primary study endpoint, or primary outcome, is whether the 3D scan's predicted probability of clinically significant Cobb angle correlates with the ground truth radiograph obtained Cobb angle at the defined rate. The percentage (%) of patient scans with predicted probabilities that correlate with ground truth results will be reported.

Secondary Outcome Measures

  1. Repeatability of 3D scan analysis [Within 48 hours]

    After the 3D scan is obtained, several personnel will align the scan relative to grid coordinates, and place a region of interest on the back of the scan. Measurements will be performed which will generate an asymmetry value, which is used to assess Cobb Angle correlation. The investigators will determine the repeatability of this manual scan assessment process.

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Ages 10 and 18 years old
Exclusion Criteria:
  • Scoliosis caused by another condition (e.g., secondary scoliosis)

  • Parents/guardians unable to consent

  • English is not the primary language (to avoid miscommunication)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University School of Medicine Palo Alto California United States 94063
2 Duke University Durham North Carolina United States 27708

Sponsors and Collaborators

  • NSite Medical

Investigators

  • Principal Investigator: Kali Tileston, MD, Stanford University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NSite Medical
ClinicalTrials.gov Identifier:
NCT06035952
Other Study ID Numbers:
  • 54101
First Posted:
Sep 13, 2023
Last Update Posted:
Sep 13, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by NSite Medical
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2023